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INTRODUCTION
More than 8 million patients with chest pain and/or anginal equivalent symptoms present to 
emergency departments (ED) each year, accounting for the second, most common cause of 
ED visits for adults.1 Cardiovascular emergencies account for approximately 10% of all ED 
visits.1,2 ED clinicians are required to rapidly differentiate between life-threatening 
conditions and non–life-threatening ones and accurately determine which course of 
treatment will result in optimal patient outcomes.3 Cardiac monitoring strategies, which 
include 12-lead electrocardiography (ECG) and bedside monitors, enable clinicians to detect 
arrhythmias, myocardial ischemia, and QT-interval measurements in real time.
Cardiac monitoring was first introduced nearly 60 years ago for critically ill patients, but 
today is used increasingly to monitor ED patients with a variety of conditions. Early 
monitoring focused on heart rate measurement and fatal arrhythmia detection.4 Today, 
monitoring has expanded to include diagnoses of complex arrhythmias, acute myocardial 
ischemia, and pharmacologically induced prolonged QT intervals.5 Emergency nurses are 
often the first care providers to evaluate patients presenting to the ED; therefore, they are 
pivotal in determining the urgency of initiating cardiac monitoring for risk stratification of 
patients arriving in the ED. Emergency nurses require ongoing education and training on 
equipment because cardiac monitoring technologies are evolving rapidly to meet the 
demands of complex, patient care. This paper describes current cardiac monitoring practices 
in an ED setting, with a primary focus on arrhythmia, myocardial ischemia, and QT-interval 
monitoring.
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Cardiac monitoring is a useful, noninvasive diagnostic tool to monitor the wide array of 
patient conditions in the ED. To assist clinicians in determining which patients need 
monitoring, experts in electrocardiology and cardiac monitoring convened to develop 
practice standards for hospital ECG monitoring.4,6 These practice standards encompass all 
areas of hospital cardiac monitoring, including arrhythmia, myocardial ischemia, and QT 
interval monitoring. Guidelines reflect expert opinions based on clinical experience and 
research; however, data for best practices for hospital cardiac monitoring are limited.6 
Conditions common to the ED setting and implications for cardiac monitoring are discussed; 
each is categorized by the rating system below, which was developed by the American 
College of Cardiology Emergency Cardiac Care Committee for cardiac monitoring.4
Class I: Cardiac monitoring is indicated in most, if not all, patients in this group.
Class II: Cardiac monitoring may be beneficial to some patients but not considered 
essential for all patients.
Class III: Cardiac monitoring is not indicated because a patient’s risk of a serious 
event is so low that monitoring has no therapeutic monitoring benefit.
ARRHYTHMIA MONITORING IN THE EMERGENCY DEPARTMENT
Arrhythmias frequently reflect underlying diseases and comorbidities, and are detected by 
clinicians as well as computer algorithms in cardiac monitors, which are set to trigger an 
alarm when a life-threatening arrhythmia is detected.7 Box 1 lists conditions for which 
arrhythmia monitoring may be beneficial (class II) or unnecessary (class III).4,6 However, 
ED patients at significant risk for immediate fatal arrhythmias, such as ventricular 
fibrillation (Fig. 1) or asystole, should receive continuous cardiac monitoring (class I).
Cardiac Arrest
Patients resuscitated from cardiac arrest should be monitored continuously for arrhythmias 
in the ED because they are at high risk for recurring arrhythmias. A cardiac monitor/
defibrillator should be attached to the patient on arrival in the ED to ascertain underlying 
rhythm and monitoring should continue until the cause of the event is known, and/or until an 
implantable defibrillator is in place.4 Patients recovering from cardiac arrest should also 
have continuing cardiac monitoring if required to leave the ED for diagnostic or therapeutic 
procedures or are transported to the intensive care unit for admission.6
Acute Coronary Syndrome
Accelerated diagnostic protocols have been developed to discern low-risk from high-risk 
patients presenting to the ED with chest pain.1 Risk stratification for patients with suspected 
acute coronary syndrome (ACS) includes prompt arrhythmia and ischemia monitoring on 
ED arrival, serial 12-lead ECG acquisition, and cardiac biomarker testing over a 6- to 12-
hour period.1,4 Patients with negative results are deemed low risk and receive a confirmatory 
study, for example, exercise and treadmill testing, before discharge.1 Alternatively, high-risk 
patients with acute myocardial infarction who undergo early reperfusion therapy in the 
prehospital period or in the ED are at risk for malignant reperfusion arrhythmias. These 
patients should receive uninterrupted, arrhythmia monitoring during both interhospital and 
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intrahospital transport.4 Arrhythmia monitoring is also indicated for patients with newly 
diagnosed, critical left main coronary artery disease and other high-risk coronary lesions 
who are candidates for urgent revascularization. Patients with unstable angina should 
undergo cardiac monitoring until infarction is ruled out and signs that transient ECG 
changes and symptoms are absent.4
Recently, Winkler and colleagues8 studied 278 patients diagnosed with ACS to determine 
the potential benefits of ST-segment monitoring in the ED; they found the incidence of 
ventricular arrhythmias (premature ventricular contractions, nonsustained ventricular 
tachycardia, and malignant arrhythmias) over the first 24 hours of hospitalization to be lower 
than studies conducted before the reperfusion era in the late 1980s.
Heart Failure and/or Pulmonary Edema
Continuous arrhythmia monitoring is recommended for patients with signs and symptoms of 
heart failure and/or pulmonary edema. Acute heart failure is a major risk factor for atrial and 
ventricular arrhythmias, and some therapies such as intravenous positive inotropic drugs 
have significant proarrhythmic properties.4
Atrioventricular Block
Patients who present to the ED with palpitations, syncope, dizziness, or lightheadedness may 
be experiencing an atrioventricular (AV) block; ongoing arrhythmia monitoring is indicated 
for patients with Mobitz I or Mobitz II (second-degree AV block), complete heart block 
(third-degree AV block), or new-onset, bundle branch block in the setting of acute 
myocardial infarction.4 ECG monitoring should continue until the block resolves or 
definitive therapy (a permanent pacemaker) is implemented.
After Cardiac Surgery
Patients presenting to the ED after cardiac surgery should be monitored for arrhythmias 
because they are at risk for developing ventricular tachycardia or fibrillation, AV block, and 
sinus node dysfunction.4 Moreover, the incidence of postoperative atrial fibrillation is 32% 
after coronary artery bypass surgery, 64% after combined bypass and mitral valve 
replacement surgery, 49% after combined bypass and aortic valve replacement, and 11% 
after heart transplantation.9,10 Emergency nurses should consider that the onset of atrial 
fibrillation typically occurs on the second to fourth postoperative days, and that a majority of 
these patients are asymptomatic.4,11
Syncope
Patients presenting to the ED with syncope of truly unknown origin should receive 
arrhythmia monitoring because heart disease is a major predictor of death and/or fatal 
arrhythmia in syncopal patients.4 Patients should be monitored until an arrhythmic cause has 
been ruled out by electrophysiologic testing or other evaluation is completed.
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ISCHEMIA MONITORING IN THE EMERGENCY DEPARTMENT
Coronary heart disease is the leading cause of death in the United States and becoming the 
most frequent cause of death worldwide.12,13 Coronary heart disease is characterized by 
stable and unstable periods, the latter reflects progression of occlusion in a coronary artery 
and manifests as ACS. ACS is a spectrum of time-sensitive clinical syndromes that includes 
(1) unstable angina, (2) non–ST-segment elevation myocardial infarction, and (3) ST-
segment elevation myocardial infarction.14 Prompt diagnosis and effective early 
management of ACS in the ED are imperative because numerous clinical trials have 
established that a more aggressive approach to the treatment of myocardial ischemia 
improves patient outcomes.4,14,15 If left undetected, ACS results in devastating outcomes 
such as myocardial infarction, heart failure, and death.15–17 Strategies to prevent infarction 
or reduce infarct size rely heavily on the ability of clinicians to identify myocardial ischemia 
in the ED. Cardiac monitoring enables clinicians to identify rapidly patients who require 
urgent intervention from those with benign conditions who can be discharged home.1,14,18,19
The 12-Lead Electrocardiogram
To date, the 12-lead ECG remains the gold standard used for initial screening, identifying, 
and evaluating patients with chest pain and anginal equivalents.20 The ECG is the most 
widely used initial diagnostic test because it is ubiquitous, noninvasive, and inexpensive, and 
provides vital information about cardiac rhythm, presence of arrhythmias, myocardial 
ischemia/infarction, and other abnormalities.15,21,22 The American College of Cardiology, 
The American Heart Association, and The European Society of Cardiology recommend that 
all patients who present to the ED with chest pain have a 12-lead ECG recorded within 10 
minutes of arrival.23–26 This recommendation is based on the premise that longer delays are 
associated with worse outcomes, and ST-segment pattern recognition shortens the delay 
between the first medical contact and life-saving reperfusion therapies.15,23,27
The standard 12-lead ECG uses 10 electrodes to record the electrical activity of the heart. 
Six precordial leads are placed across the precordium in anatomically specific locations and 
3 limb leads may be placed either (1) on the distal limbs, the preferred placement, for 
standard, resting 12-lead ECG acquisition, or (2) where the limbs attach to the torso (Mason-
Likar) for continuous ECG monitoring, such as exercise testing (Fig. 2).28 Using different 
limb lead placements produces a similar, but not identical, 12-lead ECG; different limb lead 
placement between serial ECGs may result in waveform morphology changes that computer 
algorithms falsely interpret as myocardial ischemia.4,6 Therefore, emergency nurses should 
receive ongoing training and education about the importance of correct and standardized 
electrode placement for accurate cardiac monitoring.29
Electrocardiographic Signs of Ischemia
Changes in the intracellular action potential in myocardial ischemia, injury, and infarction 
result in changes in ECG waveforms. ECG changes indicating ischemia (Fig. 3) include ST-
elevation, ST-depression, or T-wave inversion and occur before myocardial infarction, 
providing the ability to intervene to restore blood flow before myocardial cell death ensues. 
The presence of acute ischemic changes on the initial ECG, often conducted at presentation 
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to the ED, is associated with a higher risk of cardiac events.30 Acute ischemic changes are 
unpredictable and dynamic in nature, which suggests that a single snap-shot 12-lead ECG is 
inadequate, and continuous or serial ECG monitoring is superior diagnostically.20,31–33 The 
presence of ischemic signs may advise the ED clinicians to activate the catheterization 
laboratory for patients suffering from acute myocardial infarction; this extends into the 
prehospital period where paramedics may analyze ECGs acquired in the ambulance and 
activate the catheterization laboratory before hospital arrival.34
Universal ECG criteria for myocardial infarction were developed to increase the sensitivity 
and specificity of the ECG by recognizing gender, age, and lead differences.35 
Electrocardiographic criteria (in the absence of left ventricular hypertrophy and left bundle 
branch block) include:
• ST elevation at the J-point in 2 contiguous leads with the cutpoints: 0.2 mV or 
greater in men 40 years or older; 0.25 mV or greater in men less than 40 years, or 
0.15 mV or greater in women in leads V2 to V3 and/or 0.1 mV or greater in all 
other leads.
• ST-depression and T-wave changes defined by new horizontal or down-sloping 
ST depression 0.05 mV or greater in 2 contiguous leads and/or T inversion 0.1 
mV or greater in 2 contiguous leads with prominent R wave or R/S ratio of 
greater than 1.
Emergency nurses or technicians typically obtain the initial ECG in the ED, which is 
interpreted by an emergency physician or cardiologist. Because of the decreasing mentoring 
of physicians to learn ECG interpretation, there has been a recent call for the training of 
cardiovascular nurse practitioners to interpret ECG.36 This is an important consideration in 
the ED setting, where clinicians rely on interdisciplinary teamwork to manage the large 
array of patients with cardiac complaints.
Serial Electrocardiographic Monitoring
Serial ECG acquisition is recommended when the initial ECG is nondiagnostic, but patient 
signs or symptoms are consistent with acute myocardial infarction.27 Current guidelines 
specifically recommend the initial ECGs be repeated at 5- to 10-minute intervals if the initial 
ECG is not diagnostic but the patient remains symptomatic and a high clinical suspicion for 
ACS persists.37 Prior studies suggest that serial ECG recordings enhance the diagnostic 
sensitivity for ACS as compared with abnormalities on a single tracing and offer the 
opportunity for clinicians to observe changes between tracings that may be more difficult to 
interpret individually, enabling detection of evolving changes of ischemia that, by nature, are 
dynamic and unpredictable.31 Serial ECG comparisons should be made using the same 
recording technique because differences in waveform morphology have been observed 
between differing electrode configurations (eg, standard vs Mason-Likar placement).6
Continuous ST-Segment Monitoring in the Emergency Department
The American College of Cardiology/The American Heart Association guidelines 
recommend continuous bedside ST-segment monitoring for patients with a nondiagnostic 
initial ECG as an alternative to serial 12-lead ECGs.38 Patients with ACS are the highest 
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priority for ST-segment monitoring until they remain event free for 12 to 24 hours. Practice 
standards for ECG monitoring recommend continuous ST-segment monitoring in (class I) 
patients for 8 to 12 hours in combination with serum biomarker testing to determine 
treatment priority in ED patients with suspected ACS or at risk for ACS.4,18,39 Conversely, 
patients with left ventricular hypertrophy, left bundle branch block, ventricular pacing, and 
those with intermittent right bundle branch block may not necessarily benefit from ST-
segment monitoring (class III) because these conditions present secondary ST/T-wave 
abnormalities that confound interpretation and may trigger false ST-segment alarms.40
ST-segment analysis software became available on bedside monitors in the mid 1980s, and is 
widely available in the United States.39 However, surveys suggest that ST-segment 
monitoring software is not activated routinely by nurses because of lack of education, 
generations of numerous false alarms, and difficulty of use.4,41 Moreover, the standard 12-
lead ECG is not always convenient for continuous monitoring,4 especially in the ED where 
patients are on gurneys, moved frequently to accommodate patient flow, and transported for 
diagnostic testing. Improvements to the user interface may help this situation.
Studies examining the value of ST-segment monitoring in the ED are limited. Fesmire and 
colleagues32 examined the usefulness of ST-segment monitoring with serial ECG acquisition 
in 1000 patients with chest pain in the ED. Serial ECGs with ST-segment monitoring had 
greater sensitivity (68% vs 55%; P<.0001) and specificity (99 vs 97; P<.01) for detecting 
ACS compared with the initial “snapshot” ECG acquired on ED arrival. More recently, 
Bovino and colleagues18 examined the value of bedside continuous ST-segment monitoring 
163 patients with risk-stratified chest pain in the ED at intermediate risk for ACS. 
Investigators found no difference in detection of ischemia/infarction, time to diagnosis, or 
30-day adverse events among patients before and after ST-segment monitoring 
implementation.18 Further research is required to establish evidence-based guidelines for 
ST-segment monitoring in the ED setting.
Reduced Lead Sets
Reduced lead set technology enables synthesis of a 12-lead ECG from a small number of 
leads/electrodes, which makes continuous cardiac monitoring more feasible in the ED.4 The 
EASI 5-lead system (Philips IntelliVue, Andover, MA) was the first derived 12-lead ECG 
and was developed by Dower42 in 1988; it mathematically derives an ECG from 4 recording 
electrodes and a reference electrode (Fig. 4). Importantly, the derived 12-lead ECG is 
comparable with the standard 12-lead ECG for diagnosis of acute myocardial ischemia and 
wide complex QRS tachycardias, each of which requires multiple leads for accurate 
interpretation.4,43,44
Fig. 5 shows another commonly used 5-lead configuration for cardiac monitoring in the ED. 
Four limb electrodes and a fifth chest electrode can be placed in any of the standard 
precordial (V1–V6) positions; the chest electrode allows for recording of a true V lead, 
which may enhance the accuracy for arrhythmia detection.4 However, this derived lead 
configuration is not sensitive for detection of myocardial ischemia.
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QT INTERVAL MONITORING
Acute lengthening of the QT interval, an indirect measure of ventricular repolarization, can 
be observed in multiple clinical situations and is associated with syncope and sudden death 
from torsade de pointes (TdP).4 TdP is a malignant polymorphic ventricular tachycardia that 
resembles ventricular fibrillation; it may self-terminate or progress to cardiac arrest and 
sudden cardiac death (Fig. 6).4,7,45 Typical features of TdP include (1) changes in amplitude 
and morphology of QRS complexes around the isoelectric line and (2) drug-induced TdP 
episodes that begin with a short-long-short pattern of R-R cycles consisting of a short 
premature ventricular complex followed by a compensatory pause and another premature 
ventricular complex.46 A normal corrected QT (QTc) for women is less than 0.46 seconds 
and for men is less than 0.45 seconds; a QTc of greater than 0.50 seconds in either gender 
positively correlates with a higher risk for TdP. The duration of a QTc is a reliable indicator 
of risk of cardiac events; therefore, patients with long QT syndrome and associated 
ventricular arrhythmias should receive QT monitoring in the ED (class I 
recommendation).4,45
The importance of QT monitoring in the ED cannot be underestimated because ED patients 
are uniquely at risk for developing TdP owing to their vast array of chief complaints and 
high acuity.45 Specific patient characteristics are associated with development of TdP (Box 
2) and should be considered during triage and risk stratification.45
Practice guidelines recommend measuring patients’ QT/QTc interval at baseline and 
documenting repeat measures at least once every 8 hours.4,45 Patients in the ED may 
initially require QT/QTc monitoring more frequently, especially if receiving medications 
(Box 3) known to prolong the QT interval.45 Therefore, it is important for emergency nurses 
to acquire the knowledge, skill, and judgment to tailor QT/QTc monitoring to individual 
patient needs.45 Specific indications for QT interval monitoring of ED patients are listed in 
Box 4. Practice guidelines recommend that QT monitoring should continue until (1) the 
culprit drug is discontinued and/or decreased and no further prolonged QTc is noted, (2) no 
further QT-related arrhythmias occur, (3) definitive therapy (permanent pacemaker) is 
established, and/or (4) electrolyte disorder has been corrected.4,6,40
Emergency nurses are in a unique position to identify and measure the QT interval on 12-
lead ECGs acquired in the ED; they can be empowered with the knowledge of applying 
correction formulas to determine the QTc, which accounts for the influence of heart rate.45 
Moreover, ED nurses can learn to interpret and document QT measurements when provided 
by the standard 12-lead ECG machine to optimize management of patients at possible risk 
for TdP.
SUMMARY
The ED is a fast-paced, dynamic, and chaotic setting that requires quick and accurate 
decision making to distinguish high-acuity patients. The priority for emergency clinicians is 
to recognize and stabilize patients with emergent cardiovascular conditions that include, but 
are not limited to, myocardial ischemia/infarction and potentially life-threatening 
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arrhythmias. Cardiac monitoring is one of the most commonly used diagnostic practices in 
the ED, and emergency nurses are poised to use valuable information revealed in ECG 
waveforms for early triage and risk stratification. Future research is needed to drive 
evidenced-based monitoring practices specific to patients in the ED.
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KEY POINTS
• Emergency department (ED) care demands rapid, accurate diagnosis and 
stabilization of patients with time-sensitive conditions such as acute 
myocardial infarction and arrhythmia.
• Cardiac monitoring strategies in the ED include standard 12-lead 
electrocardiography and bedside monitoring for arrhythmias and myocardial 
ischemia.
• Electrocardiographic signs of myocardial ischemia drive clinical decision 
making such as the activation of cardiac catheterization of patients with ST-
elevation myocardial infarction.
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Box 1
Recommendations for cardiac arrhythmia monitoring in the emergency 
department
Class I conditions
1. Patients resuscitated from cardiac arrest.
2. Patients in the early phase of acute coronary syndrome.
3. Patients with newly diagnosed high-risk coronary lesions.
4. Patients after cardiac surgery.
5. Patients after implantation of automatic defibrillator or pacemaker lead who 
are pacemaker dependent.
6. Patients with temporary or transcutaneous pacemaker.
7. Patients with AV block (Wenckebach, Mobitz II, complete block, new-onset 
bundle branch block in the setting of myocardial infarction).
8. Patients with arrhythmia complicating Wolff–Parkinson–White syndrome 
with rapid conduction over an accessory pathway.
9. Patients with drug-induced long-QT syndrome.
10. Patients with acute heart failure, pulmonary edema.
11. Patients with major trauma, acute respiratory failure, sepsis, shock, 
pulmonary embolus, major noncardiac surgery, drug overdose, or other 
indications for intensive care.
12. Patients who require conscious sedation or anesthesia for diagnostic/
therapeutic procedures.
13. Patients with any hemodynamically unstable arrhythmia.
14. Patients with syncope owing to underlying heart condition.
15. Pediatric patients diagnosed with any arrhythmia.
Class II conditions
1. Patients with subacute heart failure.
2. Patients with do not resuscitate orders.
Class III conditions
1. Patients with chronic, rate-controlled atrial fibrillation.
2. Obstetric patients, unless heart disease is present.
Adapted from Drew BJ, Califf RM, Funk M, et al. Practice standards for 
electrocardiographic monitoring in hospital settings: an American Heart Association 
scientific statement from the Councils on Cardiovascular Nursing, Clinical Cardiology, 
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and Cardiovascular Disease in the Young: endorsed by the International Society of 
Computerized Electrocardiology and the American Association of Critical-Care Nurses. 
Circulation 2004;110(17):2721–46; and Drew BJ, Funk M. Practice standards for ECG 
monitoring in hospital settings: executive summary and guide for implementation. Crit 
Care Nurs Clin North Am 2006;18(2):157–68.
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Box 2
Characteristics of patients at risk for developing torsade de pointes
1. Women
2. Elderly
3. Heart disease
4. Acute neurologic events
5. Bradyarrhythmias with long pauses
6. Electrolyte disturbances (hypomagnesia, hypokalemia)
7. Malnutrition
8. Polypharmacy
9. Genetics (long QT syndrome, family history of sudden cardiac death, 
syncope)
10. Renal/hepatic dysfunction
Adapted from Pickham D, Drew BJ. QT/QTc interval monitoring in the emergency 
department. J Emerg Nurs 2008;34(5):428–34; with permission.
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Box 3
Medications raising patient-risk of torsade de pointes
Generic Name Clinical Use
Amiodarone Antiarrhythmic
Amiodarone Anticancer
Azithromycin Antibiotic
Chlorpromazine Antipsychotic/antiemetic
Ciprofloxacin Antibiotic
Cocaine Local anesthetic
Disopyramide Antiarrhythmic
Dofetilide Antiarrhythmic
Dronedarone Antiarrhythmic
Droperidol Antipsychotic/antiemetic
Erythromycin Antibiotic
Flecainide Antiarrhythmic
Haloperidol Antipsychotic
Ibutilide Antiarrhythmic
Levofloxacin Antibiotic
Methadone Opioid agonist
Ondansetron Antiemetic
Quinidine Antiarrhythmic
Sotalol Antiarrhythmic
Thioridazine Antipsychotic
Data from Arizona CERT. Available at: www.qtdrugs.org. Accessed December 14, 2015.
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Box 4
Indications for QT interval monitoring
1. Patients started on antiarrhythmic drug known to cause torsade de pointe 
(disopyramide, dofetilide, ibutilide, procainamide quinidine, sotalol).
2. Patients who overdose from proarrhythmic agents.
3. Patients with new onset bradyarrhythmias (complete heart block, long sinus 
pauses).
4. Patients with severe hypokalemia or hypomagnesemia.
Adapted from Pickham D, Drew BJ. QT/QTc interval monitoring in the emergency 
department. J Emerg Nurs 2008;34(5):429; with permission.
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Fig. 1. 
Example of ventricular fibrillation, a class I condition in arrhythmia monitoring.
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Fig. 2. 
Mason-Likar electrode placement for continuous 12-lead electrocardiographic monitoring. 
LA, left arm; LL, left leg; RA, right arm; RL, right leg. (From Zegre Hemsey J. Optimizing 
pre-hospital electrocardiography to improve the early diagnosis of acute coronary syndrome. 
San Francisco (CA): University of California; 2011; with permission.)
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Fig. 3. 
Changes in the electrocardiograph (ECG) in the ST-segment indicative of myocardial 
ischemia and infarction. (From Zegre Hemsey J. Optimizing pre-hospital 
electrocardiography to improve the early diagnosis of acute coronary syndrome. San 
Francisco (CA): University of California; 2011; with permission.)
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Fig. 4. 
EASI lead system electrode placement. The fifth ground electrode (not shown) may be 
placed anywhere on the body. (From Sejersten M, Pahlm O, Pettersson J, et al. Comparison 
of EASI-derived 12-lead electrocardiograms versus paramedic-acquired 12-lead 
electrocardiograms using Mason-Likar limb lead configuration in patients with chest pain. J 
Electrocardiology 2006;39(1):13–21.)
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Fig. 5. 
Standard 5-electrode lead system in the emergency department. LA, left arm; LL, left leg; 
RA, right arm; RL, right leg. (From Drew BJ, Califf RM, Funk M, et al. Practice standards 
for electrocardiographic monitoring in hospital settings: an American Heart Association 
scientific statement from the Councils on Cardiovascular Nursing, Clinical Cardiology, and 
Cardiovascular Disease in the Young: endorsed by the International Society of 
Computerized Electrocardiology and the American Association of Critical-Care Nurses. 
Circulation 2004;110(17):2721–46.)
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Fig. 6. 
Torsade de pointes is a lethal arrhythmia.
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